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Abstract. Each step in the winemaking process must be carefully planned and controlled to optimize the
quality of wine. Among others, tartaric stabilization is a critical step in enology, and although effective, the usual
practices to solve it show some qualitative limitations, and important economical and environmental impacts. For
the reasons reported above, the wine producers are searching for alternative practices, with particular interest in
the area of organic products. Biopolymers are possible alternatives in this field. The selection, the characterization
and the safety aspects of new biopolymers are the objectives of the European project STABIWINE (Use of
biopolymers for sustainable stabilization of quality wines). The first group of biopolymers analyzed includes
polyaminoacids and, in particular, polymers of L-aspartic acid (PAA), which can be used as enological additives
for tartaric stabilization. In order to contribute in drafting the toxicological dossier, the metabolic fate of PAAs
has been assessed by in vitro models, mimicking gastrointestinal digestion and absorption.
1. Introduction
The modern consumer likes a wine with bright and clear
aspect, so clarification and stabilization are important parts
of the winemaking process. Clarification is accomplished
by racking, fining, filtration and aging. Stabilization is
obtained by adding to the previous treatments chilling, ion
exchange, and the use of special additives.
One frequent cause of wine instability is the formation
of potassium bitartrate crystals, which is more evident
at low temperatures, as a consequence of a decreased
solubility. Metatartaric acid and proton exchangers are
often used for the stabilisation of wines, as well as cold
treatments; among them, the most widespread treatment
consists in maintaining the wine for one week at a
temperature close to freezing.
Although effective, the usual practices for wine
stabilization show some qualitative limitations, and
important economical and environmental impacts. At
present, the practices for tartaric, protein and oxidative
stabilization are not suitable for each type of wine and
production facility; for example, significant problems
have been observed in small wineries (conventional and
organic). Moreover, they involve a large use of energy
or water, can negatively affect overall wine quality
and processing, require the use of large quantities of
coadjuvants or additives, and can be at the origine of
significant product looses.
A possible solution is offered by the use of
biopolymers; these additives are suitable candidates to
provide new flexible, selective and inexpensive tools for
wine stabilization, which are more respectful of wine
quality and environment, and well tuned with the requests
of modern wine consumers.
The identification and the study of the most
suitable biopolymers for winemaking are the objects
of the European project named STABIWINE (“Use
of biopolymers for sustainable stabilization of quality
wines”, developed within the European Union’s Seventh
Framework Programme). The research is focused on
polyaminoacids, and in particular on polyaspartates
(PAAs), new anti-scaling additives, with an exponential
diffusion in other sectors thanks to their positive combi-
nation of efficacy, safety and price. The polyaspartates are
obtained by polymerization – through simple heating –
of aspartic acid, a widespread aminoacid; the compounds
obtained have very high surface charge, and peculiar
physical and chemical characteristics, which contribute to
their suitability for winemaking practices.
The study was aimed to produce first data useful
to the safety assessment of PAAs; in particular, the
main objectives were 1) to evaluate the proteolysis of
PAAs, using an in vitro model, which simulates the
gastrointestinal digestion, and 2) to estimate the intestinal
absorption by using CaCo-2 cells.
2. Materials and method
To simulate the human gastrointestinal digestion of
polyaspartates, an in vitro model was developed,
optimizing a sequential proteolytic attack by pepsin (from
porcine gastric mucosa, 0,7 FIP-U/mg, EC 3.3.23.1,
Merck, Damstadt, Germany), and pancreatin (from
porcine pancreas, 350 FIP-U/mg protease, 6000 FIP-U/mg
lipase, 7500 FIP-U/mg amylase, EC 232.468.9, Merck,
Darmstadt). Seven commercial PAAs, with different
chemical characteristics, were included in the study; they
are listed in Table 1.
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Table 1. Products included in the experimental activity.
Code of PAA content Average
product Form (%) MW (kDa) Cation
PAA-A Powder 80 3 Na
PAA-B Liquid 30.5 3 Na
PAA-C Liquid 28.6 10 K
PAA-D Liquid 31.2 10 Na
PAA-E Liquid 31.2 15 Na
PAA-F Liquid 29.2 5 K
PAA-G Powder 90.6 5 K
2.1. In vitro sequential gastrointestinal
proteolysis
2.1.1. In vitro gastric digestion
Different amounts of PAAs (equivalent to 24 mg of
polyaminoacid) were suspended in 8 mL of 0.06 N HCl
(pH 1-2) containing 0.05 mg/mL of pepsin. The final pro-
tein concentration was 3 mg/mL and the enzyme/protein
ratio was 1:60 (w/w). Final pH value ranged between 1.27
and 2.80, where pepsin shows the strongest activity.
The samples were incubated at 37 ◦C for 5 min, 10 min
or 2 h, in a Dubnoff water bath shaken at 100 beats/min.
Samples from gastric digestion were treated as described
below and analysed for proteolysis, or further digested by
pancreatin.
All digestions were performed in duplicate. At each
selected time of hydrolysis, samples were heated at 100 ◦C
for 10 min to stop the enzymatic activity. A “peptic blank”
sample was obtained by heating (without incubation) all
reagents, including enzymes, for 10 min at 100 ◦C.
2.1.2. In vitro intestinal digestion
At the end of gastric digestion (2 h of peptic attack), borate
buffer (2M boric acid, 1 N NaOH) containing 0.5 mg/mL
pancreatin was added in the ratio 1:3.5 (v/v) to the solution.
The hydrolysis lasted 4 or 24 hours.
All digestions were performed in duplicate. At each
selected time of hydrolysis, samples were heated at 100 ◦C
for 10 min to stop the enzymatic activity. A “pancreatic
blank” sample was obtained as described for peptic
digestion.
2.2. Quantification of proteolysis
Proteolysis was monitored by quantifying: a) the
undigested proteins by microbiuret method; and b) the
release of aminoacids by ninhydrin method.
2.2.1. Microbiuret assay
Microbiuret assay is used to quantify proteins thanks
to a specific reaction between peptidic bonds and an
alkaline reagent containing copper sulfate. The absorbance
measured at 310 nm (UV-visible spectrophotometer,
Varian Cary 50 SCAN, Palo Alto, California, U.S.A.) is
directly proportional to the concentration of polypeptides,
representing the residual proteins (undigested material).
The polypeptides were measured in the supernatant
from different digestion times, according to Itzhaki and
Gill [1]. PAA-G was used as a standard to obtain the linear
regressions (one for gastric, and another for intestinal
samples).
After different times of digestion, two aliquots of
supernatants were added with 1) copper sulfate solution
0,2% in sodium hydroxide, or 2) sodium hydroxide (30%
in water). The absorbance at 310 nm of the second aliquot
was subtracted from that of cupper reagent solution.
The polypeptide concentrations in digested samples
were determined by using a linear regression where 
310 nm absorbances (A copper sulfate – A sodium hydroxide) were
associated with known PAA concentrations.
2.2.2. Ninhydrin assay
Ninhydrin is commonly used for the detection of primary
amines, including aminoacids, which react with this
reagent forming an intense purple derivative. In this
study, the absorbance measured at 570 nm (UV-visible
spectrophotometer, Varian Cary 50 SCAN, Palo Alto,
California, USA) is proportional to the quantity of amino
acid released during digestion [2,3].
At selected times of digestion, aliquots of supernatant
were added with 2% ninhydrin solution. All solutions were
mixed, heated for 15 minutes at 100 ◦C, and finally cool
down in ice for 10 minutes.
Two linear regressions were prepared with standard
L-aspartic acid: 1) in 0.06 N HCl for peptic digestion,
and 2) in HCl/borate buffer in the ratio 1:3.5 (v/v) for
pancreatic attack.
2.3. In vitro assays with CaCo-2 cells to simulate
intestinal absorption of PAA
The effect of the selected compound on the integrity of the
gastrointestinal barrier was assessed using differentiated
CaCo-2 cells as a model of intestinal barrier. [4].
Cytotoxicity was as assessed by MTT reduction; while the
barrier integrity by the trans-epithelial electrical resistance
(TEER), using 20% of ethanol as a positive control. In-
flammation was assessed by measuring the release of IL-6,
IL-8.
In parallel, the absorption through intestinal barrier
was measured by microbiuret assay, in apical and
basolateral portion of CaCo-2 cells after 24 hours
treatment at 37 ◦C.
In this assay, biopolymer PAA-G was digested as
described above; T0 (undigested) and T2h (pepsin)+T24 h
(pancreatin) were added to CaCo-2 cells.
3. Results
3.1. Quantification of proteolysis
To assess the metabolic fate of polyaminoacids, a method
suitable to quantify the rate of digestion was necessary.
Unfortunatly, the chemical nature of the polyaspartate is
not suitable for the methods usually applied in protein
quantification. In fact, most of them [5,6] are based on the
reaction between aromatic aminoacids (present in protein
sequence) and the colorimetric reagents.
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Figure 1. Aminoacid release during in vitro gastrointestinal
digestion of PAAs. Data indicate the progression of proteolysis,
expressed as the percentage of aminoacids released/total protein.
Figure 2. Undigested PAAs during in vitro gastrointestinal
digestion. Data indicate the progression of proteolysis, expressed
as the percentage of residual polypeptides/total protein.
Due to the lack of aromatic rings, these methods are
unsuitable for this research and proteolysis was measured
applying the microbiuret method as described in 2.2.1; this
test measures the peptidic bonds in polypeptides and can
be used to quantify the undigested PAAs. The release of
aminoacids (as a measure of progressive hydrolysis) was
quantified by the ninhydrin method (2.2.2).
The proleolytic profiles of the PAA samples are shown
in Fig. 1 (free aminoacids) and Fig. 2 (undigested PAA).
The proteolytic patterns obtained in the in vitro gastro-
intestinal model show that all PAAs are very poorly
digested, with minimal pancreatic attack. In fact, the
values of released aminoacids range between 10 and 30%
after 24 h of pancreatic attack, while those of residual
polypeptides are always above 60%. Table 2 shows data
of PAA-G, the most promising product.
The values reported as “free aminoacids” could be
partially overestimated, since also terminal amino groups
of PAAs can react with ninhydrin.
3.2. Intestinal permeability
In the preliminar enological tests, PAA-G was selected
as the most promising product, so it was included in the
intestinal integrity/permeability study.
PAA-G was added to differentiated CaCo-2 cells as a
model of intestinal barrier. No changes in barrier integrity
Table 2. Proteolytic profile of PAA-G, as assayed in the
optimized in vitro gastrointestinal digestion model.
Undigested Free
Enzyme Digestion protein aminoacids
time (% of starting (% of total
value) protein)
Pepsin 0 min 100 10.90 ± 0.02
Pepsin 5 min 99.36 ± 4.38 11.48 ± 0.01
Pepsin 10 min 99.95 ± 10.91 10.95 ± 0.01
Pepsin 120 min 98.43 ± 8.20 12.30 ± 0.01
Pepsin + 2+4 hrs 98.48 ± 13.65 12.26 ± 0.04
Pancreatin
Pepsin + 2+24 hrs 99.36 ± 9.93 11.48 ± 0.02
Pancreatin
Figure 3. PAA in the apical and basolateral compartiments
after CaCo-2 treatment with T0 and T2+24 samples. Data are
espressed as percentage of polypeptide distribution.
or in cytokine release were observed, indicating that the
compound is well tollerated (data not shown).
Figure 3 shows the PAA distribution in the apical
and basolateral portion of cells, after 24 hours treatment
at 37 ◦C. Undigested PAA (T0) and sample from the
last time of proteolysis (T2+24 h) were included in the
assay.
The presence of polypeptides in the apical area ranges
between 98.3% and 96.8% for undigested and T2+24 h
sample, respectively.
The amount of PAAs dosed in basolateral portion
is very limited in both samples. The unsignificant/very
limited absorption of PAA through the intestinal barrier,
confirms data obtained by in vitro proteolysis. In other
words, PAAs and, in particular PAA-G, are poorly digested
and absorbed.
4. Conclusions
The proteolytic profile obtained with the optimized gatro-
intestinal model shows a low digestibility of PAAs; the
highest level of attack is obtained on PAA-B, where
aminoacid release reached 28% of total protein.
The proteolysis is pratically limited to the pepsin
activity. The pancreatic hydrolysis seems uneffective
and this is due to the specific composition of PAA
containing only acid aminoacids. It is well known that
endopeptidases (trypsin and chymotrypsin), contained in
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pancreatic juice, are capable to attack only peptidic
bounds including basic aminoacids. The weak proteolysis
observed during pancreatic attack is probably due to
exopeptidases (carboxy- and aminopeptidases).
The distribution of PAA-G, evaluated in the apical and
basolateral portion of CaCo-2 cells with microbiuret assay,
suggests that there is a minimal absorption through the
cell monolayer, since after 24 hrs from addition most PAA
was still found in the apical area of CaCo-2 cells scarsely
absorbed.
Data obtained in this study are the first step for the
preparation of toxicological dossier. Low digestion and
absorption are positive aspects in term of safety.
These results together with those obtained in lab-
oratory animals will contribute to define the toxico-
logical profile of the selected PAAs, as new wine
additives.
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